paclitaxel has been researched along with icaritin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ao, H; Fu, J; Guo, Y; Han, M; Huang, T; Li, H; Lu, L; Wang, X; Wang, Y; Yue, F | 1 |
| Ao, H; Fu, J; Guo, Y; Han, M; Li, H; Lu, L; Wang, X; Wang, Y | 1 |
2 other study(ies) available for paclitaxel and icaritin
| Article | Year |
|---|---|
Hydrous icaritin nanorods with excellent stability improves the
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Stability; Female; Flavonoids; Humans; Injections, Intravenous; MCF-7 Cells; Mice; Mice, Nude; Nanotubes; Paclitaxel; Particle Size | 2020 |
A Low Dose of Hydrous Icaritin Nano-Formulation with Remarkable Efficacy and Tumor Targeting in Cancer Therapy.
Topics: Cell Line, Tumor; Flavonoids; Humans; Nanoparticles; Neoplasms; Paclitaxel; Particle Size | 2021 |